{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:28:37Z","timestamp":1767338917268},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":5143,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1046\/j.0022-202x.2001.00029.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:37:48Z","timestamp":1047443868000},"page":"143-147","source":"Crossref","is-referenced-by-count":25,"title":["Mastocytosis: Review of Clinical and Experimental Aspects"],"prefix":"10.1016","volume":"6","author":[{"given":"Karin","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie B.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate M.","family":"Henz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0010","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/S0091-6749(00)91237-5","article-title":"Plasma soluble KIT levels in mastocytosis and in systemic anaphylaxis","volume":"105","author":"Akin","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0015","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1994.tb00560.x","article-title":"Urticaria pigmentosa: a review of 67 pediatric cases","volume":"11","author":"Azana","year":"1994","journal-title":"Ped Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archderm.126.10.1375","article-title":"Urticaria in monozygotic twins","volume":"126","author":"Boyano","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0040","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"B\u00fcttner","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archderm.1983.01650360067017","article-title":"Monozygotic twins discordant for cutaneous mastocytosis","volume":"119","author":"Cainelli","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<191::AID-AJH4>3.0.CO;2-Y","article-title":"Expression of bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia","volume":"60","author":"Cervero","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(08)81953-6","article-title":"Interferon treatment of patients with chronic urticaria and mastocytosis","volume":"30","author":"Czarnetzki","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2133.1981.tb00800.x","article-title":"Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate","volume":"105","author":"Czarnetzki","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0190-9622(88)70007-9","article-title":"Bone marrow findings in adult patients with urticaria pigmentosa","volume":"18","author":"Czarnetzki","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00414106","article-title":"Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes","volume":"255","author":"Czarnetzki","year":"1985","journal-title":"Arch Derm Res"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0075","first-page":"430","article-title":"System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b","volume":"42","author":"De las Nieves","year":"1997","journal-title":"Sangre"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.1999.01572.x","article-title":"The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease","volume":"106","author":"Diaz-Agustin","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2141.1995.tb05417.x","article-title":"Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease","volume":"91","author":"Escribano","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0090","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199909145725","article-title":"Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults","volume":"35","author":"Escribano","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(97)70188-X","article-title":"Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients","volume":"100","author":"Fricker","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0105","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(96)07056-0","article-title":"Mastocytosis","volume":"349","author":"Golkar","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0889-8588(05)70299-9","article-title":"Pediatric mastocytosis","volume":"14","author":"Hartmann","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0120","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/1523-1747.ep12468899","article-title":"Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital","volume":"96","author":"Horan","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0125","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","article-title":"Gastrointestinal abnormalities and involvement in systemic mastocytosis","volume":"14","author":"Jensen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0135","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0091-6749(99)70184-3","article-title":"The potential clinical utility of serum alpha-protryptase levels","volume":"103","author":"Kanthawatana","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0140","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1111\/1523-1747.ep12468942","article-title":"Pediatric mastocytosis","volume":"96","author":"Kettelhut","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcp\/91.5.558","article-title":"Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients","volume":"91","author":"Kettelhut","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response of interferon \u00e1-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1523-1747.ep12263520","article-title":"Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa. Histomorphometric, ultrastructural and biochemical investigtions","volume":"83","author":"Kolde","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2796.1996.440787000.x","article-title":"Long-term follow-up of indolent mastocytosis in adults","volume":"239","author":"Kors","year":"1996","journal-title":"J Int Med"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","article-title":"Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B","volume":"35","author":"Lehmann","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0170","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2133.1996.tb07977.x","article-title":"Long-term effect of interferon alpha treatment in mastocytosis","volume":"134","author":"Lippert","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0091-6749(96)70243-9","article-title":"Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis","volume":"98","author":"Lishner","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-8588(05)70303-8","article-title":"A proposed classification of mastocytosis incorporating molecular genetics","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0185","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0889-8588(05)70302-6","article-title":"New approaches to therapy for mastocytosis: a case for treatment with kit kinase inhibitors","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0195","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1523-1747.2000.00888.x","article-title":"Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells","volume":"114","author":"Ma","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0200","doi-asserted-by":"crossref","first-page":"13399","DOI":"10.1074\/jbc.274.19.13399","article-title":"Inhibition of spontaneous receptor phosphorylation by residues in a putative a-helix in the KIT intracellular juxtamembrane region","volume":"274","author":"Ma","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0025-6196(11)63618-5","article-title":"Systemic mast cell disease associated with the hypereosinophilic syndrome","volume":"73","author":"McElroy","year":"1998","journal-title":"Mayo Clin Proc The"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0210","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0215","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/1523-1747.ep12469022","article-title":"The liver, spleen, and lymph nodes in mastocytosis","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0220","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1111\/1523-1747.ep12469049","article-title":"The treatment of mastocytosis: an overview","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0091-6749(83)90630-9","article-title":"Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa","volume":"72","author":"M\u00fcller","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0230","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.leu.2400906","article-title":"Elevated expression of the proto-oncogene c-kit in patients with mastocytosis","volume":"12","author":"Nagata","year":"1998","journal-title":"Leukemia"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0240","first-page":"1493","article-title":"Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration","volume":"149","author":"Orfao","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0245","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1111\/1523-1747.ep12469034","article-title":"Hematologic aspects of mastocytosis: I. bone marrow pathology in adult and pediatric systemic mast cell disease","volume":"96","author":"Parker","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0250","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2340\/0001555575244","article-title":"Urticaria pigmentosa in identical male twins","volume":"75","author":"Pec","year":"1995","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0255","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117","article-title":"A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells","volume":"87","author":"Piao","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0260","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2133.1999.02814.x","article-title":"Lack of c-kit mutation in familial urticaria pigmentosa","volume":"140","author":"Rosbotham","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s002770050482","article-title":"Hodgkin's and Castleman's disease in a patient with systemic mastocytosis","volume":"78","author":"Saletti","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0270","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1365-2133.1999.02890.x","article-title":"Analysis of c-kit exon 11 and exon 17 of urticaria pigmentosa that occurred in monozygotic twin sisters","volume":"140","author":"Sato-Matsumura","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0275","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0280","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0285","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-4608(97)00386-5","article-title":"A near-haploid bone marrow karyotype in systemic mast cell disease: is it characteristic of the disease or an incidental finding?","volume":"103","author":"Shekhter-Levin","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0889-8588(05)70295-1","article-title":"Mastocytosis and the skin","volume":"14","author":"Soter","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0295","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1111\/1523-1747.ep12468973","article-title":"The skin in mastocytosis","volume":"96","author":"Soter","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(96)91600-1","article-title":"High-dose UVA1 for urticaria pigmentosa","volume":"347","author":"Stege","year":"1996","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-4608(99)00256-3","article-title":"Cytogenetic studies in patients with mastocytosis","volume":"15","author":"Swolin","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-8588(05)70294-X","article-title":"Kit signal transduction","volume":"14","author":"Taylor","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajcp\/109.3.279","article-title":"Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults","volume":"109","author":"Topar","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease: analysis of 58 cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0325","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of the literature","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin Proc The"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0330","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V83.9.2619.2619","article-title":"Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation","volume":"83","author":"Tsujimura","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0335","first-page":"385","article-title":"Biology classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wochenschr"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0345","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0091-6749(97)70131-3","article-title":"The protooncogene c-kit and c-kit ligand in human disease","volume":"100","author":"Vliagoftis","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0355","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<66::AID-AJH12>3.0.CO;2-3","article-title":"Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells","volume":"61","author":"Wimazal","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0360","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorder","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0365","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0091-6749(98)70144-7","article-title":"Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis","volume":"102","author":"Worobec","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.0022-202x.2001.00029.x_bb0370","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10428199609054789","article-title":"Treatment of three patients with systemic mastocytosis with interferon alpha-2b","volume":"22","author":"Worobec","year":"1996","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15528935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15528935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:01:36Z","timestamp":1704315696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15528935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0022202X15528935"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.00029.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}